114 related articles for article (PubMed ID: 3259251)
1. Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
Teichmann JV; Sieber G; Ludwig WD; Ruehl H
J Interferon Res; 1988 Feb; 8(1):15-24. PubMed ID: 3259251
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive effects of recombinant interferon-alpha during long-term treatment of cancer patients.
Teichmann JV; Sieber G; Ludwig WD; Ruehl H
Cancer; 1989 May; 63(10):1990-3. PubMed ID: 2702571
[TBL] [Abstract][Full Text] [Related]
3. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
[TBL] [Abstract][Full Text] [Related]
4. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F
Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543
[TBL] [Abstract][Full Text] [Related]
5. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia.
Genot E; Sarfati M; Sigaux F; Petit-Koskas E; Billard C; Mathiot C; Falcoff E; Delespesse G; Kolb JP
Blood; 1989 Nov; 74(7):2455-63. PubMed ID: 2529929
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
Griffiths SD; Cawley JC
Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
[TBL] [Abstract][Full Text] [Related]
7. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
8. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
10. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
[TBL] [Abstract][Full Text] [Related]
11. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
[TBL] [Abstract][Full Text] [Related]
13. Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment.
Marolleau JP; Henni T; Gaulard P; Le Couedic JP; Gourdin MF; Divine M; Katz A; Tulliez M; Goossens M; Reyes F
Blood; 1988 Aug; 72(2):655-60. PubMed ID: 2840988
[TBL] [Abstract][Full Text] [Related]
14. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
[TBL] [Abstract][Full Text] [Related]
15. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
17. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
Vedantham S; Gamliel H; Golomb HM
Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
[TBL] [Abstract][Full Text] [Related]
20. Hairy cell leukemia cells are relatively NK-insensitive targets.
Starling GC; Nimmo JC; Hart DN
Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]